Researchers from the University of Louisiana-Monroe are working to create an oral oleocanthal-based supplement for Alzheimer’s patients.
The use of oleocanthal-based treatments for Alzheimer’s disease continues to emerge, with the latest findings from a team of researchers at the University of Louisiana-Monroe.
The polyphenol, which gives extra virgin olive oil its distinctive throat burning sensation, has already shown promise in treatments for certain types of cancers and dementia.
The oleocanthal modulation (regulation) of C3AR1 is a very important finding that will direct future studies of oleocanthal as a plausible nutraceutical for prevention and modulation of pre-Alzheimer’s disease neurodegenerative conditions.- Khalid El Sayed, oleocanthal researcher, University of Louisiana-Monroe
Alzheimer’s disease, which is the most common form of dementia, leads to irreversible and progressive degeneration of the brain functions, including memory, personality, cognition and other vital functions.
In the United States, six million people live with Alzheimer’s disease. This figure is projected to rise to 13 million by 2050 according to the U.S. Alzheimer’s Association. An estimated 50 million people around the world live with Alzheimer’s disease.
See Also:Health NewsThe latest research, published in Nutrients, investigated the interaction between oleocanthal and the complementary peptide C3a receptor 1 (C3AR1), which is also involved in other types of neurodegenerative diseases.
“The complement system is an important element of the innate immune system, which enhances the antibodies and phagocytic cells to clear damaged cells and pathogenic microbes,” Khalid El Sayed, a pharmaceutical and toxicological sciences professor at the University of Louisiana-Monroe and co-author of the study, told Olive Oil Times.
C3AR1 is a regulatory hub in the innate immune system. In Alzheimer’s disease patients, the receptor overworks, promoting inflammation and impairing the function of the innate immune system.
The receptor behaves similarly in patients at risk of developing Alzheimer’s disease as well. The researchers said that the receptor’s deactivation leads to a decrease in tau pathology, which is a key element in the development of Alzheimer’s disease.
Therefore, “the oleocanthal modulation [regulation] of C3AR1 is a very important finding that will direct future studies of oleocanthal as a plausible nutraceutical for prevention and modulation of pre-Alzheimer’s disease neurodegenerative conditions,” El Sayed said.
The main focus of the research has been identifying new oral formulations which could soon make oleocanthal a viable treatment for the disease.
“Oleocanthal causes most of the irritative, bitter and pharyngeal taste of extra virgin olive oil,” El Sayed said. “It has a sort of highly reactive aldehyde groups, which cause high chemical and metabolic instability.”
“These are challenges that have to be addressed before using oleocanthal in human clinical trials,” he added. “We developed novel formulations that masked its undesired taste attitudes and maintained its chemical integrity.”
See Also:Mediterranean Diet May Prevent Memory Loss and Dementia SymptomsAccording to El Sayed, extra virgin olive oil consumption is believed to have a role in a lower incidence of cognitive diseases in Mediterranean nations, compared to other European and American populations.
“Oleocanthal has been reported to show promising activities against the markers of neurodegenerative insults that lead to cognitive diseases in vitro and in animal models,” he said.
“Greek extra virgin olive oil rich in phenolics [especially oleocanthal] have shown promising protective activity against early stages amyloid pathologies that lead to Alzheimer’s disease,” he added.
The research has been based on 5xFAD mice, a standard in Alzheimer’s research; the two new oral formulations found by the researchers have “maintained amyloid pathogenesis suppressive activity by reducing the β‑amyloid accumulation in the mouse brains,” the study reads.
The new formulations, explained the researchers, “significantly improved its pharmacodynamics effects and delivery in Alzheimer’s diseases animal models.”
In order for the two new supplements to reach the market, El Sayed said “oleocanthal has yet to be pre-clinically tested as a single entity in Alzheimer’s disease patients so that it can earn investigational new drug approval from the Food and Drug Administration.”
“We actually patented our new formulations and have plans to commercialize oleocanthal nutraceutical and dietary supplement using these formulations in the near future,” he added.
However, the research is ongoing with pre-clinical examinations planned.
“We need to understand more about the in vivo metabolic fate of oleocanthal and validate the short and long-term safety for its use, which are top priorities before clinical testing,” El Sayed concluded.
More articles on: Alzheimer's, health, oleocanthal
Jul. 26, 2023
Mediterranean Diet Associated with Successful Aging, Study Finds
Researchers found that Greeks who followed the Mediterranean diet were healthier and more active as they aged than those who followed the diet less closely.
Jan. 3, 2024
Promoting the Role of Women in the Olive Sector
Jill Myers founded the Women in Olive Oil network to connect women across the sector while promoting their voices and highlighting their contributions.
Apr. 9, 2024
The Role of Monounsaturated Fatty Acids in Olive Oil's Health Benefits
Oleic acid, classified as a monounsaturated fatty acid (MUFA), has been extensively studied by scientists over the last decades, consistently demonstrating many positive effects on human health.
Sep. 6, 2023
Israeli Firm Prepares to Launch Countertop Olive Oil Appliance
The countertop appliance that transforms olives into olive oil in less than an hour could be available in 2024.
Aug. 10, 2023
Researchers Work to Reverse Genetic Erosion, Breed Resilient Olive Varieties
Understanding the genetic diversity of olive varieties will help farmers select the best cultivars for their climate and phytosanitary environment.
Oct. 24, 2023
Olive Grove Bacteria May Hold Key to Combating Xylella
Certain microorganisms provide biological advantages like a secondary immune system, researchers found.
Feb. 20, 2024
New Research Rekindles Debate on Nutri-Score’s Effectiveness
The OECD found Nutri-Score could save money on healthcare. Dutch researchers questioned the integrity of studies supporting the labeling system.
Sep. 28, 2023
Regenerative Ag Practices Improve Profitability of Steep-Slope Olive Farms
After finding that soil health improved in abandoned steep-slope olive groves, researchers determined organic and regenerative farming could yield similar results.